Anti-angiogenesis therapy for the treatment of ovarian cancer

摘要

OF THE DISCLSOURE This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of 5 human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer. 6774520_1 (GHMatters) P90981.AU.1 LEOWNR